UHN Foundation
The UHN Foundation (UHNF), short for the University Health Network Foundation, is a Canadian charitable organization based in Toronto, Ontario.
Affiliations
Donors
UHNF has received in the range of $10-25 million from Gilead Sciences and Roche.1) Additional multi-million dollar donors include Abbott, AbbVie, Actelion, Amgen, Apotex, Astellas, AstraZeneca, Axcan, Baxter, Bayer, Bell, BlueRock Therapeutics, BMO Financial Group, Boehringer Ingelheim, Centre for Commercialization of Innovative Medicine, CIBC, CymaBay Therapeutics, Deloitte, Ernst & Young, GlaxoSmithKline, Imperial Oil, Janssen, Johnson & Johnson, KPMG Foundation, Loblaws, Lundbeck, Manulife, Medtronic, Merck, Novartis, Otsuka, Pfizer, the RBC Foundation, Research Manitoba, Rogers Communications, Scotiabank, Barry Sherman, Honey Sherman, Sun Life Financial, Synthes, TD Bank Group, and the University of Toronto.
1)
2020/21 Report to Our Donors. UHN Foundation. Retrieved May 6, 2022, from https://web.archive.org/web/20220507012703/https://uhnfoundation.ca/who-we-are/publications/2020-21-report-to-our-donors/